# Staodyne, Inc.

- Location (FDA's records): Longmont, CO
- FDA decisions: 9 (1992–1995): 9 510(k) clearances
- Product codes: GZJ (5), IPF (3), GXY (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 6 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Compex Technologies, Inc.: 2 (https://510kreport.com/company/compex-technologies)
- Newwave Medical, LLC: 1 (https://510kreport.com/company/newwave-medical)
- Rehabilicare, Inc.: 1 (https://510kreport.com/company/rehabilicare)
- Bio-Medical Research, Ltd.: 1 (https://510kreport.com/company/bio-medical-research)
- Stellar Medical, LLC: 1 (https://510kreport.com/company/stellar-medical)

## Its most-cited devices
- K926510: Staodyn Ems+2 (1993), cited by 4
- K930865: Staodyn Maxima Iii (1993), cited by 1
- K921668: Staodyn Tuwave (1992), cited by 1

## Recent decisions
- K952680: Varapulse-2 (Dec 4, 1995)
- K941923: Sterile Treatment Electrode (Jun 2, 1995)
- K931925: TPK Cutaneous Electrode (Aug 16, 1993)
- K926510: Staodyn Ems+2 (Aug 11, 1993)
- K931424: Maxima I (Jun 4, 1993)
- K930865: Staodyn Maxima Iii (May 13, 1993)
- K925898: Model 19 Stimulator, Nerve, Transcutaneous (Jan 28, 1993)
- K921110: TENS (Aug 14, 1992)

Source page: https://510kreport.com/company/staodyne